Literature DB >> 871133

Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin.

C Watanakunakorn, I M Baird.   

Abstract

Data on 40 patients with Staphylococcus aureus endocarditis treated with appropriate antibiotics in adequate dosage at the University of Cincinnati Medical Center hospitals between January 1961 and June 1975 were analyzed. The overall mortality was 40 per cent. The mortality was 11.1 per cent in patients under 50 years old and 63.6 per cent in patients over 50 years old (p less than 0.01). Seven patients were narcotic addicts who had no underlying disease and were under 50 years old; all survived. For patients without underlying diseases, the mortality was 0 per cent in those under 50 years old and 75 per cent in those over 50 years old. Patients who died had a greater number of major underlying diseases (pre-existing cardiac disease, diabetes mellitus, alcoholism and/or cirrhosis) than the survivors. Patients over 50 years old had significantly more major underlying diseases than patients under 50 years old (p less than 0.001). Among patients over 50 years old, those who died had more complications than the survivors while the number of underlying diseases were comparable. A group of patients treated with gentamicin during the first two to three weeks of therapy in addition to a penicillin was compared to a similar group treated with a single antibiotic. The mortality of both groups was 40 per cent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871133     DOI: 10.1097/00000441-197703000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

1.  Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  Brian T Tsuji; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Staphylococcus aureus: The persistent pathogen.

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-11

3.  Interaction between vancomycin and rifampin against Staphylococcus aureus.

Authors:  C Watanakunakorn; J C Guerriero
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

4.  Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.

Authors:  M H Miller; M A Wexler; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 5.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

6.  Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study.

Authors:  T L Lemonovich; K Haynes; E Lautenbach; V K Amorosa
Journal:  Infection       Date:  2011-09-06       Impact factor: 3.553

7.  The Effectiveness of Combination Therapy for Treating Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Literature Review and a Meta-Analysis.

Authors:  Sara Grillo; Mireia Puig-Asensio; Marin L Schweizer; Guillermo Cuervo; Isabel Oriol; Miquel Pujol; Jordi Carratalà
Journal:  Microorganisms       Date:  2022-04-20

8.  Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin.

Authors:  L Coppens; B Hanson; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Clindamycin therapy of experimental Staphylococcus aureus endocarditis.

Authors:  W M Scheld; M L Johnson; E B Gerhardt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Nafcillin therapy for Staphylococcus aureus endocarditis.

Authors:  H Masur; H W Murray; R B Roberts
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.